ÇALI, A. Et Al. 2022. FDA-APPROVED MOLECULAR TESTS USED TO DEFINE HUMAN PAPILLOMAVIRUS (HPV) INFECTIONS WHICH CAUSES CERVIX CANCER. III. International Cancer Days , (Sivas, Turkey).

ÇALI, A., ASLAN, R., ÇELİK, C., & ALİM, A., (2022). FDA-APPROVED MOLECULAR TESTS USED TO DEFINE HUMAN PAPILLOMAVIRUS (HPV) INFECTIONS WHICH CAUSES CERVIX CANCER . III. International Cancer Days, Sivas, Turkey

ÇALI, ABDULHAMİT Et Al. "FDA-APPROVED MOLECULAR TESTS USED TO DEFINE HUMAN PAPILLOMAVIRUS (HPV) INFECTIONS WHICH CAUSES CERVIX CANCER," III. International Cancer Days, Sivas, Turkey, 2022

ÇALI, ABDULHAMİT Et Al. "FDA-APPROVED MOLECULAR TESTS USED TO DEFINE HUMAN PAPILLOMAVIRUS (HPV) INFECTIONS WHICH CAUSES CERVIX CANCER." III. International Cancer Days , Sivas, Turkey, 2022

ÇALI, A. Et Al. (2022) . "FDA-APPROVED MOLECULAR TESTS USED TO DEFINE HUMAN PAPILLOMAVIRUS (HPV) INFECTIONS WHICH CAUSES CERVIX CANCER." III. International Cancer Days , Sivas, Turkey.

@conferencepaper{conferencepaper, author={ABDULHAMİT ÇALI Et Al. }, title={FDA-APPROVED MOLECULAR TESTS USED TO DEFINE HUMAN PAPILLOMAVIRUS (HPV) INFECTIONS WHICH CAUSES CERVIX CANCER}, congress name={III. International Cancer Days}, city={Sivas}, country={Turkey}, year={2022}}